Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Competition waiting on FDA approval

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Aug 13, 2021 3:56pm

183 Views

Post# 33702203

RE:RE:Competition waiting on FDA approval

Wow. I had some options on SESN that just sold for a small profit yesterday. So lucky. random luck.

Incidentally, our drug candidate wouldn't be in a BLA application pipeline as far as I can see. Not a protein or immunotherapy? Seems BLA's have much bigger approval challenges around production quality.

Correct?

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute